Skip to content

General Pharmaceutical Council patient safety spotlight: the risks of overprescribing Salbutamol inhalers for asthma (31 May 2022)

Summary

Specialist inspectors have identified cases of Salbutamol inhaler overprescribing of up to six inhalers per prescription by online prescribers. This article explores the risks of prescribing high volumes of Salbutamol inhalers. It highlights the need for ongoing patient monitoring, counselling advice, inhaler device choices and discuss the clinical considerations when continuing treatment.

General Pharmaceutical Council patient safety spotlight: the risks of overprescribing Salbutamol inh… https://www.pharmacyregulation.org/regulate/article/patient-safety-spotlight-risks-overprescribing-s…

User Feedback

Recommended Comments

There are no comments to display.

Create an account or sign in to comment

Registered address: Patient Safety Learning, China Works SB203, 100 Black Prince Road Vauxhall, London, SE1 7SJ

Account

Navigation

Search

Search

Configure browser push notifications

Chrome (Android)
  1. Tap the lock icon next to the address bar.
  2. Tap Permissions → Notifications.
  3. Adjust your preference.
Chrome (Desktop)
  1. Click the padlock icon in the address bar.
  2. Select Site settings.
  3. Find Notifications and adjust your preference.